GRAIL, Inc. Common Stock
Not enough financial coverage to compute a composite score for GRALV. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companygrail.com
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests.
- CEO
- Robert P. Ragusa
- HQ
- Menlo Park, CA, US
Price Chart
Performance & Tape
- 52W High
- $23.36
- 52W Low
- $12.51
- 50D MA
- $15.94
- 200D MA
- $15.94
- Beta
- 0.00
- Avg Volume
- 2.37M
Get TickerSpark's AI analysis on GRALV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GRALV Coverage
We haven't published any research on GRALV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GRALV Report →